Building better vasculature

Genes and Development

Volumn 15, Issue 19, 2001, Pages 2497-2502

  Bruick, R K ^a   McKnight, S L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; HYPOXIA INDUCIBLE FACTOR 1; PR 39; RECOMBINANT VASCULOTROPIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; GENE OVEREXPRESSION; GENE THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR VASCULARIZATION; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; ENDOTHELIAL GROWTH FACTORS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035476508     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.931601     Document Type: Review

References (65)

1. Amino acid sequence of PR-39
2. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
3. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
4. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
5. Somatic gene therapy in the cardiovascular system
6. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
7. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1a
8. Vascular endothelial growth factor enhances atherosclerotic plaque progression
9. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability
10. Hypoxia inducible factor-a binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
11. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
12. Endothelial signal integration in vascular assembly
13. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
14. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
15. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing
16. Induction of hypervascularity without leak or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1a
17. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-reduced interaction with CBP/p300
18. Molecular and biological properties of vascular endothelial growth factor
19. VEGF: An update on biological and therapeutic aspects
20. Clinical applications of angiogenic growth factors and their inhibitors
21. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
22. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
23. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
24. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha
25. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
26. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
27. 2 sensing
28. 2 homeostasis by hypoxia-inducible factor 1 alpha
29. 2-regulated prolyl hydroxylation
30. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension
31. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha
32. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway
33. Activation of HIF1α ubiqui-tination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
34. Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases
35. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
36. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
37. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
38. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
39. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
40. PR39, a peptide regulator of angiogenesis
41. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
42. Vascular endothelial growth factor (VEGF) and its receptors
43. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1alpha
44. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
45. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
46. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit
47. HIF-1α is required for solid tumor formation and embryonic vascularization
48. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
49. 2 homeostasis by hypoxia-inducible factor 1
50. HIF-1 and human disease: One highly involved factor
51. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
52. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
53. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-α) proteins
54. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
55. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
56. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
57. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
58. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
59. Angiopoietin-1 protects the adult vasculature against plasma leakage
60. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
61. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
62. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
63. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor
64. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
65. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha